Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule

EU orphan designation number: EU/3/09/709   
Active ingredient: Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule
Indication: Treatment of glioma
Sponsor: Apogenix GmbH
Im Neuenheimer Feld 584, 69120 Heidelberg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Orphan designation EMEA/OD/098/09 (2010)657 of 28/01/2010